CollPlant Biotechnologies Ltd Ordinary Shares
CLGN
Closed
$0.36
Closed
-(-)
At close
Get professional financial guidance
Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply
About
CollPlant Biotechnologies Ltd. operates as a regenerative and aesthetic medicine company. The company is headquartered in Rehovot, Central(Hamerkaz) and currently employs 39 full-time employees. The firm provides products and technologies for broadly understood regenerative medicine, including tissue regeneration and organ production. The technology is based on plants and is based on the production of collagen type I (rhCollagen).
Key stats
Open
$0.36
Volume
9.00K
Market cap
$5.19M
Prev. close
$0.36
Impl / hst vl
-
Open interest
$0.00
$0.36
Day’s Range
$0.36
$0.27
52W Range
$1.99
Valuation
33
Valuation score
Overvalued
P/E
-
P/S
13.61
P/B
1.08
Current ratio
2.27
Debt / Equity
-0.87
ROE
-160.28%
Gross margin
-332.88%
Income growth
-3.43%
FCF growth
3.56
Analysts estimates
Consensus rating
Buy
The average rating from top 4 analysts indicates that stock is expected to perform in line with the market
Str. Sell
Sell
Hold
Buy
Str. Buy
Avg. price target
$11.22
The top 3 analysts forecasts that 12-month price may increase by 3,016.67%, with a low of $11.11 and a high of $11.55
$11.11
Low
$11.22
Avg
$11.55
High
Current price
Earnings
Q1 ‘26 revenue
$73.00K
Q1 ‘26 net income
-$3.10M
Revenue
Net income
Previous EPS
-Estimate EPS
$0.06
Actual EPS
Estimate EPS
Explore the Healthcare sector
Get professional financial guidance
Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply